Phase II Randomized Trial:Arginine Butyrate Plus Standard Local Therapy in Patients With Refractory Sickle Cell Ulcers

NCT00004412 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Skin Ulcers
Sickle Cell Anemia

Interventions

DRUG: Arginine Butyrate
OTHER: Standard local care dressing

Sponsor

Susan P. Perrine

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]